We were very interested to read the article by [@b1-ehp-117-a140]. The difference between maternal exposure and our own data on actual concentrations of poly cyclic aromatic hydrocarbons (PAHs) in the human male fetal liver ([@b2-ehp-117-a140]) was striking. Eight of the PAH exposures meas ured by Choi et al. were also on our list of PAHs measured in the human fetal liver during the second trimester.

Assuming that the 48-hr samples of airborne PAH exposure used by [@b1-ehp-117-a140] truly reflect longer-term exposure more relevant to the outcomes under consideration (which is contentious because the measurements may either over estimate or underestimate true exposure), then we can approximate a comparison between the two studies. Therefore, we calculated the fold- difference between the maximal second trimester exposures (nanograms per cubic meter) reported by Choi et al. in their Table 2 and the mean male fetal liver values presented in our Table 3 \[([@b2-ehp-117-a140]), corrected to nanograms per kilogram dry weight\]. We calculated values separately for fetuses from mothers who smoked cigarettes and for those who did not ([Table 1](#t1-ehp-117-a140){ref-type="table"}). The smallest difference was 5-fold for benzo\[*a*\]pyrene (BaP), whereas the largest difference was 8,340-fold for benz\[*a*\]anthracene (BaA), in all cases representing accumulation in the fetal liver considerably above personal maternal exposure to airborne PAHs. Of course there are other sources of exposure to PAHs, such as air pollution and occupational sources, but these data very clearly suggest that large quantities of PAHs are crossing the placenta and accumulating in the fetus. Perhaps even more interesting was the very different relative proportions of these eight PAHs in the air compared with in fetal livers: BaA comprised 11% in air but 94--96% in the livers, whereas pyrene was 17% in the air but below detection in the livers. This suggests that very different proportions of PAHs are accumulating in fetal tissues and it also underscores the fundamental principle that to really understand health risks we cannot afford to ignore the actual tissue levels in favor of exposure estimates alone.

###### 

Maximum air PAH exposure (ng/m^3^) compared with mean human male fetal liver PAH levels (ng/kg dry weight) from mothers who did and did not smoke, during the second trimester.

                               PAH concentration   Relative proportion of PAH                                                
  ---------------------------- ------------------- ----------------------------------------------- --------- ------- ------- -------
  BaA                          39.69               331,000                                         195,000   11.14   95.47   93.80
  Benzo\[*b*\]fluoranthene     67.47               1,300                                           1,800     18.93   0.38    0.87
  Benzo\[*k*\]fluoranthene     20.33               500                                             1,000     5.71    0.14    0.48
  Benzo\[*ghi*\]perylene       32.26               800                                             200       9.14    0.23    0.10
  BaP                          42.23               500                                             200       11.85   0.14    0.09
  Chrysene                     31.13               11,000                                          9,000     8.73    3.17    4.33
  Dibenzo\[*a,h*\]anthracene   10.76               800                                             200       3.02    0.24    0.09
  Indeno\[1,2,3-*cd*\]pyrene   50.20               800                                             500       14.09   0.23    0.24
  Pyrene                       61.96               0[a](#tfn1-ehp-117-a140){ref-type="table-fn"}   0         17.39   0       0

Below detection in human fetal livers.
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